Caitong International Asset Management Co., LTD Tarsus Pharmaceuticals, Inc. Call Options Transaction History
Caitong International Asset Management Co., LTD
- $140 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TARS
# of Institutions
217Shares Held
46.9MCall Options Held
7.8KPut Options Held
0-
Black Rock Inc. New York, NY3.27MShares$227 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.11MShares$216 Million1.94% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.98MShares$207 Million5.63% of portfolio
-
Jennison Associates LLC2.6MShares$181 Million0.09% of portfolio
-
Tang Capital Management LLC San Diego, CA2.45MShares$170 Million5.96% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.85B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...